Marker Therapeutics, Inc. (MRKR) › Capital ExpendituresMarker Therapeutics, Inc. (MRKR) — Capital ExpendituresAnnual figures by period end, from SEC filings.2017-12-31: $02018-12-31: $147.7K2019-12-31: $375.0K$375.0K2017-12-31Capital Expenditures (USD)2019-12-31Period endedCapital ExpendituresChange YoYSource filing2019-12-31$375.0K+153.9%2020-03-12From 2019-01-012018-12-31$147.7K—2020-03-12From 2018-01-012017-12-31$0—2019-03-15From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)